Knight Therapeutics Inc.
↗Montreal, Canada
Knight Therapeutics Inc. is a leading pan-American specialty pharmaceutical company headquartered in Montreal, Canada. The company focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and Latin American markets. Through its subsidiary, Grupo Biotoscana (GBT), Knight maintains a robust commercial presence across 10 Latin American countries, including Brazil, Mexico, Colombia, and Argentina.
Knight's business model is centered on commercializing late-stage innovative products and branded generics rather than early-stage drug discovery. The company manages a diverse portfolio across several high-growth therapeutic areas, including oncology, hematology, infectious diseases, and central nervous system (CNS) disorders. Knight is known for its strategic partnerships with global pharmaceutical firms to bring specialized treatments to underserved regional markets.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Specialty Pharmaceuticals
SIZE & FINANCIALS
Employees:501-1000
Revenue:$370M-$420M CAD
Founded:2014
Ownership:public
Status:operating
FUNDING
Stage:Public
Investors:Jonathan Ross Goodman, Fidelity Investments, T. Rowe Price
STOCK
Exchange:TSX
Ticker:GUD
Market Cap:$426M CAD
PIPELINE
Stage:Commercial
Lead Drug Stage:Approved/Commercial
Modalities:Small molecule, Biologic, Branded Generic
Active Trials:6
Trial Phases:Phase 2: 2 | Phase 3: 1 | Phase 4: 3
FDA Approvals:1
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Grupo Biotoscana (GBT), United Medical, LKM, DOSA
Key Partnerships:Incyte (Oncology products in LATAM), Rigel Pharmaceuticals (Tavalisse), Amryt Pharma (Lojuxta), Eisai (Lenvima, Halaven), Gilead (Ambisome in LATAM)
COMPETITION
Position:Leader
Competitors:Bausch Health, HLS Therapeutics, Pharmascience, Eurofarma, Aché Laboratórios
LEADERSHIP
Key Executives:
Samira Sakhia - CEO
Jonathan Ross Goodman - Executive Chairman
Arvind Utchanah - CFO
Scientific Founders:Jonathan Ross Goodman
Board Members:James Gale, Robert Lande, Janice Murray, Michael Tremblay, Nicolás Sujoy
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Knight Therapeutics Inc.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.